# An Open-Label Study of DCCR Tablet in Patients With PWS

> **NCT04086810** · PHASE3 · WITHDRAWN · sponsor: **Soleno Therapeutics, Inc.**

## Conditions studied

- Prader-Willi Syndrome

## Interventions

- **DRUG:** DCCR

## Key facts

- **NCT ID:** NCT04086810
- **Lead sponsor:** Soleno Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was never initiated; rather the duration of open-label study C602 (NCT03714373) was extended.
- **Last updated:** 2021-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086810, "An Open-Label Study of DCCR Tablet in Patients With PWS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04086810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*